United Therapeutics | UTHR - Bénéfice Avant Impôts

Prix De L'Action
567.16
Variation Quotidienne
-5.69 -0.99%
Mensuellement
4.72%
Annuel
94.65%
Q2 Prévisions
575.44




Bénéfice Avant Impôts Changement Date
Amarin USD -852K 7.26M 2025-12
Ardelyx USD -400K 467K 2025-12
Baxter International USD 121M 12M 2025-09
Bayer EUR -1.16B 735M 2025-09
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Esperion Therapeutics USD 63.67M 95M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Insmed USD -326.93M 41.77M 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
J&J USD 7.82B 2.86B 2026-03
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Moderna USD -187M 631M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Pfizer USD 3.33B 290M 2025-09
PTC Therapeutics USD -139.08M 116.01M 2025-12
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Teva Pharmaceutical Industries USD 91M 555M 2025-12
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09